X-Chem - About the company
X-Chem is an acquired company based in Waltham (United States), founded in 2009 by Richard Wagner. It operates as a Provider of small molecule drug discovery platform for researchers. X-Chem has raised $8.5M in funding. The company has 3 active competitors, including 1 that has exited. Its top competitors are 1859, Cephalogix and ChemStitch.
Company Details
Provider of small molecule drug discovery platform for researchers. The company is focused on discovering small molecule drugs using its DNA-Encoded X-Chem (DEX) drug discovery platform. The platform is a product engine and is based on a library generated by the combinatorial synthesis of small molecules tethered to DNA tags that record the synthetic history of the small molecule. The library is screened as a mixture using affinity-based binding to a target of interest and then the bound molecules are detected using DNA sequencing which can have therapeutic applications.
- Website
- www.x-chemrx.com/
- Email ID
- *****@x-chemrx.com
- Registered Address
- Waltham, Massachusetts
Key Metrics
Founded Year
2009
Location
Waltham, United States
Stage
Acquired
Total Funding
$8.5M in 1 round
Latest Funding Round
Ranked
1st among 3 active competitors
Employee Count
197 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Acquired by Enko Chem (Jun 15, 2022)
Legal entities associated with X-Chem
X-Chem is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
X-CHEM INC CIN: 300596178 , United States, Active | Dec 26, 999 | - | 54 (As on Dec 31, 2024) | - |
X-Chem's acquisition details
X-Chem got acquired by Enko Chem on Jun 15, 2022.
Click here to take a look at X-Chem's acquisition in detail
Sign up to download X-Chem's company profile
X-Chem's funding and investors
X-Chem has raised a total funding of $8.5M over 1 round.
Here is the list of recent funding rounds of X-Chem:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 21, 2012 | 2848902 | Series A | 9312500 | 4156978 | 9560016 | 9470352 |
View details of X-Chem's funding rounds and investors
X-Chem's founders and board of directors
Founder? Claim ProfileThe founders of X-Chem is Richard Wagner.
Here are the details of X-Chem's key team members:
- Richard Wagner: Founder & CEO of X-Chem. They are also an angel investor in 3 startups.
View details of X-Chem's Founder profiles and Board Members
X-Chem's employee count trend
X-Chem has 197 employees as of Aug 26. Here is X-Chem's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
X-Chem's Competitors and alternates
Top competitors of X-Chem include 1859, Cephalogix and ChemStitch. Here is the list of Top 10 competitors of X-Chem, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | X-Chem 2009, Waltham (United States), Acquired | Provider of small molecule drug discovery platform for researchers | $8.5M | - | 60/100 |
2nd | 1859 2019, San Diego (United States), Deadpooled | Provider of DNA encoded libraries for drug discovery and development | $49.7M | 35/100 | |
3rd | ![]() Cephalogix 2020, Unfunded | Developer of cheminformatics software for drug discovery | - | - | 16/100 |
4th | ![]() ChemStitch Unfunded | Developer of an AI-powered, browser-based chemical structure editor platform | - | - | 16/100 |
Looking for more details on X-Chem's competitors? Click here to see the top ones
X-Chem's Investments and acquisitions
X-Chem has not made any investments yet. X-Chem has made 4 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 28, 2021 | Acquisition | 2020 | London (United Kingdom) | |
Oct 25, 2021 | Acquisition | 2006 | Budapest (Hungary) | |
Jan 26, 2021 | Acquisition | 2016 | San Diego (United States) |
See all acquisitions by X-Chem
Reports related to X-Chem
Here is the latest report on X-Chem's sector:
News related to X-Chem
Media has covered X-Chem for 1 event in last 1 year, It was about partnerships.
•
•
•
•
Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug DiscoveryBusiness Wire•Sep 05, 2024•X-Chem, Evotec, Scientist.com
•
X-Chem Strengthens Its Data-Driven Discovery Services With New CBO AppointmentBusiness Wire•Jun 20, 2024•X-Chem
•
X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery StrategyBusiness Wire•Apr 02, 2024•X-Chem
•
X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive OfficerBusiness Wire•Jan 04, 2024•X-Chem
•
X-Chem Announces Achievement of Collaboration MilestoneBusiness Wire•Dec 05, 2023•X-Chem, Relay Therapeutics
•
•
Ipsen: Christelle Huguet Appointed To The Position Of Executive Vice-president, Director Of Research And DevelopmentMyPharma Editions•Sep 01, 2023•Ipsen, X-Chem
Are you a Founder ?
FAQs about X-Chem
Explore our recently published companies
- Solar - Indore based, 1994 founded, Unfunded company
- Bina Punjani - India based, 2011 founded, Unfunded company
- Aviator - India based, Unfunded company
- Admit Beacon - India based, 2021 founded, Unfunded company
- Origin Itfs - Chennai based, 1993 founded, Unfunded company
- 1Win - India based, 2026 founded, Unfunded company
